Five days next the main outcome evaluation day. As well as PTSD symptom enhancement, the ketamine group exhibited markedly bigger reduction in comorbid depressive symptoms than the midazolam group, which is notable presented the high comorbidity of depression in people with PTSD. Research conclusions even further prompt that repeated ketamine https://fredl999pfu8.blogolenta.com/profile